# Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal Carcinoma

> **NCT03165344** · NA · COMPLETED · sponsor: **Peking University Third Hospital** · enrollment: 66 (actual)

## Conditions studied

- Esophageal Stenosis Acquired

## Interventions

- **OTHER:** Hydrocortisone sodium succinate mixed with Aluminium Phosphate gel (route of administration)
- **OTHER:** Triamcinolone Acetonide (route of administration)
- **OTHER:** Prednisone (route of administration)

## Key facts

- **NCT ID:** NCT03165344
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-10
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03165344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03165344, "Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03165344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*